Bupivacaine

(Redirected from Bupivicaine)

General

  • Type: Local anesthetics
  • Dosage Forms: injectable solution
  • Dosage Strengths: 0.25%, 0.5%, 0.75%
  • Routes of administration: Infiltration
  • Common Trade Names: Marcaine, Sensorcaine

Maximum Doses of Anesthetic Agents

Agent Without Epinephrine With Epinephrine Duration Notes
Lidocaine 5 mg/kg (max 300mg) 7 mg/kg (max 500mg) 30-90 min
  • 1% soln contains 10 mg/ml
  • 2% soln contains 20 mg/ml
Mepivicaine 7 mg/kg 8 mg/kg
Bupivicaine 2.5 mg/kg (max 175mg) 3 mg/kg (max 225mg) 6-8 hr
  • 0.5% soln contains 5 mg/ml
  • May cause cardiac arrest if injected intravascularly
  • Do not buffer with bicarbonate
Ropivacaine 3 mg/kg
Prilocaine 6 mg/kg
Tetracaine 1 mg/kg 1.5 mg/kg 3hrs (10hrs with epi)
Procaine 7 mg/kg 10 mg/kg 30min (90min with epi)

Adult Dosing

Pediatric Dosing

Special Populations

  • Pregnancy Rating: C
  • Lactation: Infant risk is minimal
  • Renal Dosing
    • Adult
    • Pediatric
  • Hepatic Dosing
    • Adult
    • Pediatric

Contraindications

  • Allergy to class/drug
  • Obstetric paracervical block

Adverse Reactions

  • Due to increased potency and duration, higher risk of toxicity than other local anesthetics [1]

Serious

  • Negative ionotropy, hypotension, cardiac arrest
  • Respiratory arrest
  • CNS depression, CNS excitation, bacterial meningitis, seizure

Common

Pharmacology

  • Half-life: ~3-8 hours
  • Metabolism: Liver
  • Excretion:

Mechanism of Action

  • Amide-type local anesthetic; stabilizes the neuronal membranes → blocks initiation and transmission of nerve impulses

See Also

References

  1. Yaster, M, Tobin, et al. Local anesthetics. In: Pain In Infants, Children, And Adolescents, 2nd edition, Schechter, NL, Berde, CB, Yaster, M (Eds), Lippincott, Williams & Wilkins, Philadelphia, PA 2003. p.241.